SCHEMBL26423449

SCHEMBL26423449

c1cnc2nc3c(nc2c1)oc1ncccc13

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 3/20 0.39
DHFR P00374 1/20 0.36
PIK3CA P42336 4/20 0.36
LMNA P02545 1/20 0.36
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35
F7 P08709 1/20 0.35
F3 P13726 1/20 0.35
MAPT P10636 2/20 0.35
MAPK14 Q16539 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CHRNA7 P36544 1/20 0.34
HTR3A P46098 1/20 0.34
CYP3A4 P08684 1/20 0.33
PIK3R1 P27986 1/20 0.33
MTOR P42345 1/20 0.33
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423457 0.93 KDM4E (0.39) KDM4EALDH1A1DHFRPIK3CALMNA
SCHEMBL26423369 0.86 KDM4E (0.45) KDM4EALDH1A1DHFRPIK3CALMNA
SCHEMBL26423470 0.78 MAPK14 (0.38) KDM4EALDH1A1DHFRF2F10
SCHEMBL26423458 0.77 MAPK14 (0.37) KDM4EALDH1A1F2F10F7
SCHEMBL26423479 0.77 KDM4E (0.39) KDM4EALDH1A1LMNAMAPTMAPK14
SCHEMBL26423487 0.76 KDM4E (0.43) KDM4EALDH1A1PIK3CALMNAMAPT
SCHEMBL26423451 0.76 KDM4E (0.36) KDM4EALDH1A1PIK3CALMNAF2
SCHEMBL26423453 0.76 KDM4E (0.36) KDM4EALDH1A1PIK3CALMNAF2
SCHEMBL13344056 0.73 ALDH1A1 (0.48) KDM4EALDH1A1LMNAMAPTMAPK14
SCHEMBL11884983 0.73 KDM4E (0.55) KDM4EALDH1A1PIK3CALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 KDM4E 2800/4885ALDH1A1 302/4885DHFR 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.